http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34087836

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 2296-2565
pageRange 881034-
publicationName Frontiers in Public Health
startingPage 881034
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_177b7d5759b08c2ffc5d92d31a4c9e1d
bibliographicCitation Feng M, Chen Y, Yang Y, Li Q. Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis. Front Public Health. 2022;10():881034. PMID: 35619813; PMCID: PMC9127138.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_521c80ac4889bd59a2d6ff8f446ff1d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc8272c9d1d99a5f65b7f40f242ab98c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ba31e1394eeadb1a79081b52dfaf59c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/35619813
https://doi.org/10.3389/fpubh.2022.881034
https://pubmed.ncbi.nlm.nih.gov/PMC9127138
isPartOf https://portal.issn.org/resource/ISSN/2296-2565
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41731
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis
discusses http://id.nlm.nih.gov/mesh/M0586473
http://id.nlm.nih.gov/mesh/M0018350
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0016578
http://id.nlm.nih.gov/mesh/M000626416
http://id.nlm.nih.gov/mesh/M0575909
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016889Q000188
http://id.nlm.nih.gov/mesh/D000074322Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D010671
http://id.nlm.nih.gov/mesh/D011804
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003362
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823820
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9950

Total number of triples: 37.